Status:
COMPLETED
COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020
Lead Sponsor:
Grand Hôpital de Charleroi
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The management of the Grand Hôpital de Charleroi hospital authorized the performance of a serology for each member of the establishment's staff in order to better characterize the proportion of its em...
Detailed Description
At the start of the SARS-CoV-2 pandemic, several workers had symptoms compatible with COVID-19 at a time when PCR (smear) testing was only allowed for hospitalized people. In addition, the PCR test ha...
Eligibility Criteria
Inclusion
- Be a member of the staff of the Grand Hôpital de Charleroi who wishes to participate in order to know their immunity related to SARS CoV-2 after the first wave of pandemic.
Exclusion
- Not be part of the staff of the Grand Hôpital de Charleroi.
Key Trial Info
Start Date :
June 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
2817 Patients enrolled
Trial Details
Trial ID
NCT04723290
Start Date
June 20 2020
End Date
December 31 2020
Last Update
March 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Grand Hôpital de Charleroi
Charleroi, Hainaut, Belgium, 6060